GENOMIC HEALTH INC Contracts & Agreements
56 Contracts & Agreements
- Business Finance (3 contracts)
- Business Operations (2)
- Human Resources (10)
- Mergers & Acquisitions (1)
- Real Estate (10)
- Uncategorized (30)
- Agreement and Plan of Merger, dated as of July 28, 2019, by and among Exact Sciences Corporation, Spring Acquisition Corp. and Genomic Health, Inc (Filed With SEC on July 30, 2019)
- Sublease between the Company and Acelrx Pharmaceuticals, Inc., dated as of January 3, 2019 (Filed With SEC on May 9, 2019)
- Genomic Health, Inc. Severance Plan for Executive Management, as amended (Filed With SEC on March 14, 2018)
- Genomic Health, Inc. Severance Plan for Executive Management, International Version (Filed With SEC on March 14, 2018)
- Genomic Health, Inc. Deferred Compensation Plan (Filed With SEC on November 9, 2017)
- Genomic Health, Inc. Amended and Restated 2005 Stock Incentive Plan, as amended (Filed With SEC on August 4, 2017)
- Genomic Health, Inc. Employee Stock Purchase Plan, as amended (Filed With SEC on August 4, 2017)
- INDEMNIFICATION AGREEMENT (Filed With SEC on May 19, 2017)
- GENOMIC HEALTH, INC. AMENDED AND RESTATED 2005 STOCK INCENTIVE PLAN (Adopted by the Board on September 8, 2005, and amended and restated by the Board on January 26, 2016) (Filed With SEC on August 9, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 9, 2016)
- FIRST AMENDMENT TO LEASE (Filed With SEC on March 9, 2016)
- SECOND AMENDMENT TO LEASE (Filed With SEC on March 9, 2016)
- LEASE BETWEEN METROPOLITAN LIFE INSURANCE COMPANY (LANDLORD) AND GENOMIC HEALTH, INC. (TENANT) SEAPORT CENTRE Redwood City, California (Filed With SEC on March 9, 2016)
- THIRD AMENDMENT TO LEASE (Filed With SEC on March 9, 2016)
- SECOND AMENDMENT TO LEASE (Filed With SEC on March 9, 2016)
- GENOMIC HEALTH, INC. 2005 STOCK INCENTIVE PLAN (Adopted by the Board on September 8, 2005, and amended and restated by the Board on April 25, 2015) (Filed With SEC on August 6, 2015)
- Genomic Health, Inc. Severance Plan For Executive Management (Filed With SEC on May 7, 2015)
- FIRST AMENDMENT TO LEASE (Filed With SEC on November 6, 2014)
- GENOMIC HEALTH, INC. 2005 STOCK INCENTIVE PLAN (Adopted by the Board on September 8, 2005, and amended and restated by the Board on March 19, 2014) (Filed With SEC on August 8, 2014)
- GENOMIC HEALTH, INC. EXECUTIVE CASH BONUS PLAN (Filed With SEC on August 8, 2014)
- CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. (Filed With SEC on March 14, 2012)
- GENOMIC HEALTH, INC. EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on August 8, 2011)
- FIRST AMENDMENT TO LEASE (Filed With SEC on March 11, 2011)
- SECOND AMENDMENT TO LEASE (Filed With SEC on March 11, 2011)
- GENOMIC HEALTH, INC. 2005 STOCK INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT GRANT (Filed With SEC on March 11, 2011)
- Current assets (Filed With SEC on November 9, 2009)
- Current assets (Filed With SEC on August 7, 2009)
- Current assets (Filed With SEC on August 7, 2009)
- Current assets (Filed With SEC on November 10, 2008)
- Exhibit No (Filed With SEC on May 22, 2007)
- LEASE BETWEEN METROPOLITAN LIFE INSURANCE COMPANY (LANDLORD) AND GENOMIC HEALTH, INC. (TENANT) SEAPORT CENTRE Redwood City, California (Filed With SEC on March 16, 2007)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on September 26, 2005)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 20, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on September 9, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on September 9, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on September 9, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on August 22, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
- Improved Quality of Treatment Decisions. We believe our approach to genomic-based cancer analysis improves the quality of cancer treatment decisions by providing an individualized... (Filed With SEC on July 15, 2005)
